A central goal of the Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical problems that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.
normal term human infants, even if early enteral feeding is withheld, this phenomenon is selflimited, as glucose levels spontaneously rise within 2 to 3 hours. [1] [2] [3] This early self-limited period of hypoglycemia should not be considered pathologic. There is little practical value in measuring, or treating, the blood glucose concentrations of asymptomatic, normal term babies in the first 2 hours after birth. [4] [5] [6] Furthermore, even in those situations in which low blood glucose concentrations do develop secondary to prolonged intervals (>8 hours) between breastfeedings, 2 a marked ketogenic response occurs The enhanced capability of the neonatal brain to use ketone bodies provides glucose-sparing fuel to the brain, protecting neurologic function. 2, [7] [8] [9] Studies have not shown that treating transiently low blood glucose levels results in better short-or long-term outcomes compared with no treatment, and in fact there is no evidence that asymptomatic hypoglycemic infants benefit from treatment at all. 10 Koivisto et al. 11 
ABM Protocols

PURPOSE T
O PROVIDE GUIDANCE in the first hours/days of life to:
• Prevent hypoglycemia in breastfed infants • Monitor blood glucose levels in at risk term and late-preterm breastfed infants • Manage documented hypoglycemia in breastfed infants • Establish and preserve maternal milk supply during medically necessary supplementation for hypoglycemia
BACKGROUND
Physiology
The term hypoglycemia refers to a low blood glucose concentration. Transient hypoglycemia in the immediate newborn period is common, occurring in almost all mammals. In healthy, found no difference in neurologic outcome between asymptomatic hypoglycemic infants and euglycemic control infants, with 94% and 95% of each group normal on 1-to 4-year follow-up. There was a significant (12%) increase in neurologic abnormalities in symptomatic hypoglycemic infants and a 50% incidence of neurologic abnormalities when seizures were present. The compensatory provision of alternate fuels constitutes a normal adaptive response to transiently low nutrient intake during the establishment of breastfeeding, 2,12 resulting in breastfed infants tolerating lower plasma glucose levels without any significant clinical manifestations or sequelae. 12 Therefore, the monitoring of blood glucose concentrations in healthy, appropriately grown neonates is unnecessary, and potentially harmful to parental well-being and the successful establishment of breastfeeding. 4, 6, 13, 14 
Definition of hypoglycemia
The definition of hypoglycemia in the newborn infant has remained controversial because of a lack of significant correlation among plasma glucose concentration, clinical symptoms, and long-term sequelae. 12, 15, 16 In addition, blood glucose test results vary enormously with the source of the blood sample, the assay method, and whether whole blood, plasma, or serum glucose concentration is determined. Plasma or serum glucose concentrations are 10% to 15% higher than in whole blood. 17 Breastfed, formula-fed, and mixed-fed infants follow the same pattern of glucose values with an initial fall in glucose over the first 2 hours, followed by a gradual rise in glucose over the next 96 hours, whether fed or not. 1, 18, 19 Breastfed infants tend to have slightly lower glucose and higher ketone bodies than artificially fed infants. 2, 18, 20, 21 The incidence of "hypoglycemia" varies with the definition. 22 Many authors have suggested numeric definitions of hypoglycemia, usually between 30 and 50 mg/dL (1.7 to 2.8 mmol/L) and varying by postnatal age. 1, 4, 15, 18, [22] [23] [24] [25] [26] Cornblath et al. 12 summarized the problem:
Significant hypoglycemia is not and can not be defined as a single number that can be applied universally to every individual patient. Rather, it is characterized by a value(s) that is unique to each individual and varies with both their state of physiologic maturity and the influence of pathology.
A recent metaanalysis (studies published 1986 to 1994) of low plasma glucose thresholds in full-term normal newborns who were mostly mixed-fed (formula and breastfeeding) or formula-fed, presented recommended low thresholds for plasma glucose based on hours after birth ( Table 1 ). The authors specifically noted that given the lower plasma glucose levels in normal breastfed infants, the low thresholds for exclusively breastfed infants might even be lower. 27 Recommendations based on this threshold approach are provided in Table 1 .
Given this information, it is clear that the routine monitoring of blood glucose in healthy term infants is not only unnecessary, but is potentially harmful to the establishment of a healthy mother-infant relationship and successful breastfeeding patterns. 6, 13, 14, 28, 29 This recommendation has been supported by the World Health Organization, 4 the AAP, 30 and the National Childbirth Trust of the United Kingdom. 31 They all conclude that early and exclusive breastfeeding is safe to meet the nutritional needs of healthy term infants and that healthy, full-term infants do not develop symptomatic hypoglycemia simply as a result of underfeeding.
Testing methods
Bedside glucose testing strips are inexpensive and practical, but are not reliable with significant variance from true blood glucose levels. 14, 26, 32 Bedside glucose tests may be used for screening, but laboratory levels must confirm results before a diagnosis of hypoglycemia can be made, especially in asymptomatic infants. 4, 14, 17, 28 
RISK FACTORS FOR HYPOGLYCEMIA
Neonates at increased risk for developing neonatal hypoglycemia should be routinely monitored for blood glucose levels irrespective of the mode of feeding. At risk neonates fall into two main categories:
1. Excess use of glucose, which includes the hyperinsulinemic states 2. Inadequate production or substrate delivery 33 The infant categories as shown in Table 2 are at increased risk for hypoglycemia. 5, 12, [33] [34] [35] [36] 
CLINICAL MANIFESTATIONS OF HYPOGLYCEMIA
The clinical manifestations of hypoglycemia are nonspecific, occurring with a variety of other neonatal problems. Even in the presence of an arbitrary low glucose level, the physician must assess the general status of the infant by observation and physical examination to rule out other disease entities and processes that may need additional laboratory evaluation and treatment. Some common clinical signs are listed in Table 3 .
A diagnosis of hypoglycemia also requires that symptoms abate after normoglycemia is restored. Transient, single, brief periods of hypoglycemia are unlikely to cause permanent neurologic damage. 5, 10, 28 
GENERAL MANAGEMENT RECOMMENDATIONS (TABLE 4)
Early and exclusive breastfeeding meets the nutritional and metabolic needs of healthy, term newborn infants. Healthy term infants do not develop symptomatic hypoglycemia simply as a result of underfeeding. 4 Glucose screening should be performed only on at-risk infants and those with clinical symptoms compatible with hypoglycemia.
Routine monitoring of blood glucose in
asymptomatic, term newborns is unnecessary and may be harmful. 4,5,31,38,39 2. At-risk infants should be screened for hypoglycemia with a frequency and duration related to the specific risk factors of the individual infant. 5 It is suggested that monitoring begin within 30 to 60 minutes for infants with suspected hyperinsulinemia, and no later than 2 hours of age for infants in other risk categories. 3. Monitoring should continue, until normal, preprandial levels are consistently obtained. 4. Bedside glucose screening tests must be confirmed by formal laboratory testing.
MANAGEMENT OF DOCUMENTED HYPOGLYCEMIA (TABLE 5)
Asymptomatic infant:
1. Continue breastfeeding (approximately every 1 to 2 hours) or feed 3 to 5 mL/kg (up to 10 mL/kg) 4 of expressed breast milk or 
SUPPORTING THE MOTHER
Having an infant who was thought to be normal and healthy and who develops hypoglycemia is both concerning to the mother and family, and may jeopardize breastfeeding. Mothers should be reassured that there is nothing wrong with their milk, and supplementation is usually temporary. Having the mother hand-express or pump milk that is then fed to her infant can overcome feelings of maternal inadequacy as well as help establish a full milk supply. It is important to provide stimulation to the breasts by manual or mechanical expression with appropriate frequency (eight times in 24 hours) until her baby is latching and suckling well to protect her milk supply. Keeping the infant at the breast, or returning the infant to the breast as soon as possible is important. Skin-to-skin care is easily done with an IV and may lessen the trauma of intervention, while also providing physiologic thermoregulation, contributing to metabolic homeostasis.
RECOMMENDATIONS FOR FUTURE RESEARCH
1. Well-planned, well-controlled studies are needed that look at plasma glucose concentrations, clinical symptoms, and long-term sequelae so the levels of glucose necessary for intervention can be better understood. 2. The development of more reliable bedside testing methods would increase the efficiency of diagnosis and treatment of significant glucose abnormalities. 3. A clearer understanding of the role of other glucose-sparing fuels and methods to measure them in a clinically meaningful way and time frame would aid in understanding which babies are truly at risk of neurologic sequelae, and thus must be treated.
CONCLUSION
Healthy, full-term infants are programmed to make the transition from their intrauterine constant flow of nutrients to their extrauterine intermittent nutrient intake without the need for metabolic monitoring or interference with the natural breastfeeding process. 3 Homeostatic mechanisms ensure adequate energy substrate is provided to the brain and other organs, even when feedings are delayed. The normal pattern of early, frequent, and exclusive breastfeeding meets the needs of healthy full-term infants. Routine screening or supplementation are not necessary and may harm the normal establishment of breastfeeding.
